ATE533757T1 - Neues pyridinderivat mit wirkung gegen helicobacter pylori - Google Patents

Neues pyridinderivat mit wirkung gegen helicobacter pylori

Info

Publication number
ATE533757T1
ATE533757T1 AT07715278T AT07715278T ATE533757T1 AT E533757 T1 ATE533757 T1 AT E533757T1 AT 07715278 T AT07715278 T AT 07715278T AT 07715278 T AT07715278 T AT 07715278T AT E533757 T1 ATE533757 T1 AT E533757T1
Authority
AT
Austria
Prior art keywords
gastric
helicobacter pylori
pyridine derivative
pyroli
effect against
Prior art date
Application number
AT07715278T
Other languages
English (en)
Inventor
Masaharu Ito
Masaichi Yamamoto
Original Assignee
Arigen Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arigen Pharmaceuticals Inc filed Critical Arigen Pharmaceuticals Inc
Application granted granted Critical
Publication of ATE533757T1 publication Critical patent/ATE533757T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Communicable Diseases (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT07715278T 2006-03-10 2007-03-07 Neues pyridinderivat mit wirkung gegen helicobacter pylori ATE533757T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2006066431 2006-03-10
PCT/JP2007/054387 WO2007105551A1 (ja) 2006-03-10 2007-03-07 抗ヘリコバクター・ピロリ作用を有する新規ピリジン誘導体

Publications (1)

Publication Number Publication Date
ATE533757T1 true ATE533757T1 (de) 2011-12-15

Family

ID=38509384

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07715278T ATE533757T1 (de) 2006-03-10 2007-03-07 Neues pyridinderivat mit wirkung gegen helicobacter pylori

Country Status (18)

Country Link
US (1) US20090143438A1 (de)
EP (1) EP2003130B1 (de)
JP (1) JP5053992B2 (de)
KR (1) KR101348643B1 (de)
CN (1) CN101400670B (de)
AT (1) ATE533757T1 (de)
AU (1) AU2007225935B2 (de)
BR (1) BRPI0708601A2 (de)
CA (1) CA2645467C (de)
DK (1) DK2003130T3 (de)
ES (1) ES2374730T3 (de)
HK (1) HK1122290A1 (de)
MX (1) MX2008011594A (de)
PL (1) PL2003130T3 (de)
PT (1) PT2003130E (de)
RU (1) RU2433126C2 (de)
SI (1) SI2003130T1 (de)
WO (1) WO2007105551A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102001024B1 (ko) 2017-09-29 2019-07-17 서울프로폴리스 주식회사 프로폴리스를 포함하는, 위염 및 헬리코박터 파일로리 억제를 위한 조성물
KR102041615B1 (ko) 2017-09-29 2019-11-06 서울프로폴리스 주식회사 원산지가 다른 프로폴리스 추출물을 혼합 사용하는 프로폴리스의 사용방법 및 프로폴리스를 유효성분으로 하는 건강기능식품용 조성물

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL66340A (en) 1981-08-13 1986-08-31 Haessle Ab Pharmaceutical compositions comprising pyridylmethyl-thiobenzimidazole derivatives,certain such novel derivatives and their preparation
JPS6150978A (ja) * 1984-08-16 1986-03-13 Takeda Chem Ind Ltd ピリジン誘導体およびその製造法
JPS6150979A (ja) * 1984-08-16 1986-03-13 Takeda Chem Ind Ltd ピリジン誘導体およびその製造法
FI90544C (fi) * 1986-11-13 1994-02-25 Eisai Co Ltd Menetelmä lääkeaineina käyttökelpoisten 2-pyridin-2-yyli-metyylitio- ja sulfinyyli-1H-bensimidatsolijohdannaisten valmistamiseksi
JPH0674272B2 (ja) * 1986-11-13 1994-09-21 エーザイ株式会社 ピリジン誘導体及びそれを含有する潰瘍治療剤
JP2694361B2 (ja) 1989-02-09 1997-12-24 アストラ アクチエボラグ 抗菌剤
JPH0720865B2 (ja) 1989-02-10 1995-03-08 武田薬品工業株式会社 抗菌剤
ES2066120T3 (es) * 1989-02-10 1995-03-01 Takeda Chemical Industries Ltd Uso de derivados de bencimidazol como agentes antibacterianos.
JPH0348680A (ja) 1989-07-18 1991-03-01 Yoshitomi Pharmaceut Ind Ltd 抗菌剤
JP2798588B2 (ja) 1992-08-21 1998-09-17 エーザイ株式会社 抗菌剤
ATE192932T1 (de) * 1993-09-09 2000-06-15 Takeda Chemical Industries Ltd Formulierung enthaltend einen antibakteriellen und einen antiulcus wirkstoff
JPH07126189A (ja) * 1993-09-09 1995-05-16 Takeda Chem Ind Ltd 抗潰瘍併用療法用製剤
HUT76639A (en) * 1994-07-20 1997-10-28 Byk Gulden Lomberg Chem Fab Pyridyl-thio-compounds, process for producing them and their use
ES2214802T3 (es) 1994-08-30 2004-09-16 Nagase Chemtex Corporation Intermedios para la preparacion de derivados de esteres de acido guanidinometilciclohexanocarboxilico.
EP0870500B1 (de) 1995-12-22 2008-02-20 Nagase ChemteX Corporation Wirkstoff gegen helicobacter pylori
CN1205632A (zh) * 1995-12-22 1999-01-20 帝国化学产业株式会社 抗幽门螺杆菌剂
ES2171116B1 (es) * 2000-04-14 2003-08-01 Esteve Quimica Sa Procedimiento para la obtencion de derivados de (((piridil sustituido)metil)tio)bencimidazol.
JP4490765B2 (ja) 2004-08-24 2010-06-30 株式会社東芝 熱−電気直接変換装置

Also Published As

Publication number Publication date
CA2645467A1 (en) 2007-09-20
MX2008011594A (es) 2008-09-22
EP2003130A2 (de) 2008-12-17
RU2008140164A (ru) 2010-04-20
WO2007105551A1 (ja) 2007-09-20
KR101348643B1 (ko) 2014-01-08
EP2003130A4 (de) 2010-12-22
HK1122290A1 (en) 2009-05-15
SI2003130T1 (sl) 2012-02-29
EP2003130B1 (de) 2011-11-16
CN101400670A (zh) 2009-04-01
AU2007225935B2 (en) 2011-12-22
RU2433126C2 (ru) 2011-11-10
US20090143438A1 (en) 2009-06-04
BRPI0708601A2 (pt) 2011-06-07
AU2007225935A1 (en) 2007-09-20
CN101400670B (zh) 2012-10-10
DK2003130T3 (da) 2011-12-12
ES2374730T3 (es) 2012-02-21
JP5053992B2 (ja) 2012-10-24
JPWO2007105551A1 (ja) 2009-07-30
EP2003130A9 (de) 2009-04-15
PT2003130E (pt) 2012-01-10
PL2003130T3 (pl) 2012-04-30
CA2645467C (en) 2012-04-24
KR20090005292A (ko) 2009-01-13

Similar Documents

Publication Publication Date Title
RS52823B (en) NEW UNITS USEFUL FOR TREATMENT OF DEGENERATIVE AND INFLAMMATORY DISEASES
EA200500814A1 (ru) Производные пирролопиримидина
MX2009006742A (es) Inhibidores acilaminopirazoles como fgfr.
RS52435B (en) PROTEAZOMA INHIBITORS
RS52323B (en) 2'-FLUORO-2'-DEOKSITETRAHIDROURIDINI KAO INHIBITORI CITIDIN DEAMINAZE
EA200970585A1 (ru) Бензамидные производные как агонисты ер-рецепторов
WO2007009656A3 (de) Neues 1,4-benzothiazepin-1,1-dioxidderivat mit verbesserten eigenschaften, verfahren zu dessen herstellung, diese verbindung enthaltende arzneimittel und dessen verwendung
BRPI0511512A (pt) derivados pirrolpirimidina úteis no tratamento do cáncer
MX2009004096A (es) Metabolitos de talarozol.
WO2007135527A3 (en) Benzimidazolyl compounds
EA200700096A1 (ru) Производные 2-карбамид-4-фенилтиазола, способ их получения и их применение в терапии
BRPI0515499A (pt) derivados de piridina para a inibição de estearoil-coa-desaturase humana
ATE307810T1 (de) Imidazol-2-carbonsäureamid derivate als raf- kinase-inhibitoren
WO2008019967A3 (en) Phenyl, pyridine and quinoline derivatives
CY1111481T1 (el) Υποκατεστημενα αρυλοκυκλοπροπυλακεταμιδια ως ενεργοποιητες γλυκοκινασης
PE20080768A1 (es) Compuestos de isoindolina 5-sustituidos
BRPI0409627A (pt) 2-hidróxi-3-diaminoalcanos de fenacila
CY1110034T1 (el) Παραγωγα 1,2,4,5-τετραϋδρο-3h-βενζαζεπινων, μεθοδος παρασκευης αυτων και οι φαρμακευτικες συνθεσεις που τα περιεχουν
WO2007024843A3 (en) Pyrimidinyl-pyrazole inhibitors of aurora kinases
EA200802173A1 (ru) Производные терфенила для лечения болезни альцгеймера
NO20075409L (no) Substituerte aminoalkyl- og amidoalkyl-benzopyranderivater
RU2009127750A (ru) Препарат против helicobacter pylori, ингибирующий секрецию желудочного сока
BRPI0412636A (pt) imidazopirimidinas substituìdas para a prevenção e tratamento de cáncer
ATE533757T1 (de) Neues pyridinderivat mit wirkung gegen helicobacter pylori
EA200870223A1 (ru) Производные бензоизоиндола для лечения боли